Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $102.32 which represents a slight increase of $0.05 or 0.05% from the prior close of $102.27. The stock opened at $102.28 and ...

Boston Scientific (BSX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Boston Scientific Corp. closed 0.01% short of its 52-week high of $101.65, which the company reached on January 22nd.

Deutsche Bank has recently raised Boston Scientific Corp (BSX) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on October 18, 2024, Needham had reduced the stock ...

Results from the single-arm trial saw 63.5% of patients able to avoid the symptoms of Atrial fibrillation over the course of ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...